Background: Chronic kidney disease has become a leading public health concern in China, as it is associated with increased morbidity, mortality, and costs. However, the overall situation regarding common glomerular diseases in China remains unclear. Hence, the aim of this study was to assess the national profile of the common types of glomerulonephritis in China. Methods: We searched Medline, Embase, Cochrane Library, CNKI, SinoMed, VIP, and Wanfang databases for English and Chinese language articles from inception to September 2017. We also collected potentially relevant studies and reviews using a manual search. The following words in combinations are as keywords: "renal biopsy", "kidney pathological diagnosis", and "spectrum of pathological types". Results: We identified 23 studies involving 176,355 patients from 15 provinces/cities in China. The detection rates of primary glomerulonephritis (PGN) and secondary glomerulonephritis (SGN) were 0.740 and 0.221, respectively. Over the past 30 years, the top five types of PGN were immunoglobulin A nephropathy (IgAN; 24.3%), mesangial proliferative glomerulonephritis (MsPGN; 10.5%), membranous nephropathy (MN; 12.6%), minimal change disease (MCD; 9.8%), and focal segmental glomerulosclerosis (FSGS; 4.6%), and the top four types of SGN were lupus nephritis (LN; 8.6%), Henoch-Schönlein purpura glomerulonephritis (4.1%), hepatitis B virus-associated glomerulonephritis (HBV-GN; 2.6%), and diabetic nephropathy (DN; 1.6%). The proportion of MN, MCD, HBV-GN, and DN tended to increase, while those of IgAN, MsPGN, FSGS, and LN tended to drop. Conclusions: Although the incidence of SGN is increasing gradually, PGN is still the leading form of kidney disease in patients undergoing renal biopsies in China. IgAN and LN are the most common types of PGN and SGN, respectively. Differences between regions are related to various factors such as nationality, environment, and diet. Furthermore, unified standards and norms for evaluating renal biopsies are urgently needed.
IntroductIon
In recent years, chronic kidney disease (CKD) has become a leading public health concern in China and other countries, [1] as it is associated with increased morbidity, mortality, and financial costs. The overall prevalence of CKD in China ranges from 10.8% to 13%. [2] Despite numerous studies, there are no early diagnostic markers for CKD. [3] The renal biopsy is still the golden diagnostic criterion for nephropathy.
The first renal biopsies in China were performed in the 1980s. Now, they are performed widely in tertiary hospitals. [4, 5] Some hospitals have reported on the spectrum of pathological types seen in renal biopsies, but the overall situation regarding the common types of glomerular disease in China remains unclear. The distribution of the spectrum of glomerular disease varies temporally and geographically and in different ethnic groups. [6] Few studies have systematically investigated the spectrum of primary glomerulonephritis (PGN) and secondary glomerulonephritis (SGN) in China when stratified by geographic region and time period. Therefore, this study was focused on the detection rate of different types of glomerulonephritis and aimed to assess the national profile of the common types of PGN and SGN in China.
Methods
This systematic review followed the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions, [7] and the report complies with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. [8] The protocol and registration information are available at http:// www.crd.york.ac.uk/PROSPERO/(CRD 42017082724).
Search strategy
We performed a systematic electronic search of the PubMed, Embase, Cochrane Library, SinoMed (Chinese Biomedical Literature Database), Chinese National Knowledge Infrastructure (CNKI), VIP, and Wanfang databases from their inceptions through September 2017.
All articles written in either Chinese or English containing any word regarding pathological types of renal biopsy were identified; the following words in combinations are as keywords: "renal biopsy," "kidney pathological diagnosis," and "spectrum of pathological types." After completing the electronic database search, we performed a manual search of professional journals and thesis.
Inclusion and exclusion criteria
Studies that met the following inclusion criteria were included in the review: (1) renal biopsy performed in a hospital located in China; (2) more than 1000 cases were reported in the study; (3) the total cases of renal biopsy, PGN, and SGN were reported or could be calculated; and (4) detection rates of various types of glomerular diseases were reported or could be calculated.
Studies were rejected for the following reasons: (1) inclusion of data from other countries or regions and (2) limits placed on age or gender.
Record selection and data extraction
Two authors (Yang Y and Zhang Z) performed the initial search independently, deleted duplicate records, screened the titles and abstracts for relevance, and identified records as included, excluded, or uncertain. In the case of uncertainty, a third researcher (Zhuo L) was responsible for examining the data and discussing the findings with the other two. Studies were included only when all three researchers reached a consensus.
Data were extracted by Yang Y and confirmed independently by two other authors (Zhang Z and Zhuo L). We also sought supplementary appendices of the included studies or contacted the corresponding authors to verify the extracted data and request any missing data. Discrepancies were resolved by discussion with the coauthors. The predefined outcomes were the detection rates of the top five types of PGN and top four types of SGN and their proportion trends.
results

Basic information regarding the studies included
The electronic and manual searches identified 2027 potentially relevant papers. After browsing the titles and abstracts, we selected 421 papers. After reading the entire texts of these 421 papers, we excluded 398 papers and included 23 papers, [4, with a total of 176,355 patients from 15 different provinces/cities in China. According to the geographical and administrative divisions, we divide our country into five regions: north, east, south, west, and central China, at least two studies were included in each region. In east and south China, the economically developed regions, more than 130,000 cases were enrolled, and even in west China, there are still more than 10,000 cases. The process of paper inclusion is shown in Supplementary Figure 1 , and the detailed information on the studies is summarized in Table 1 .
Detection rate of the main primary glomerulonephritis in China
The detection rate of PGN to renal biopsy patients in China was based on 22 studies [4, involving 170,420 cases. The detection rate of PGN was 0.740 (126,031 cases).
IgA nephropathy (IgAN, 24.3%), mesangial proliferative glomerulonephritis (MsPGN, 10.5%), membranous nephropathy (MN, 12.6%), minimal change disease (MCD, 9.8%), and focal segmental glomerulosclerosis (FSGS, 4.6%) were the most common pathological types. Pathological data were also analyzed with different regions of China [ Table 2 ].
Detection rate of the main secondary glomerulonephritis in China
The detection rate of SGN to renal biopsy patients in China was based on 23 studies [4, involving 176,355 cases. The detection rate of SGN was 0.221 (38,979 cases).
Lupus nephritis (LN, 8.6%), Henoch-Schönlein purpura glomerulonephritis (HSP-GN, 4.1%), hepatitis B virus-associated nephritis (HBV-GN, 2.6%), and diabetic nephropathy (DN, 1.6%) were the most common pathological types. Pathological data were also analyzed with different regions of China [ Table 3 ].
Trends in frequency of the most common glomerulopathies in China
To observe the changing trend of disease spectrum of renal biopsy, we set three periods: before 2000 (period 1), 2001-2010 (period 2), and after 2010 (period 3).
The trends of PGN proportion were based on 16 studies [4,5, IgAN may be the most common type of PGN worldwide. While the detection rate in Africa was <5%, [31] it was 17.8-22.0% in America, [32, 33] 26-37% in Europe, [34, 35] and up to 30-40% in Asia. [36, 37] In countries in East Asia, the detection rate of MsPGN in a broad sense (IgAN and non-IgA MsPGN) can exceed 50%. [36, 37] Obviously, ethnic and genetic factors play important roles. The prevalence of IgAN and MsPGN has decreased in the recent decades. The main reasons for this may be that other types of PGN, such as MN, have increased and PGN is being diagnosed more accurately, while MsPGN tended to be misdiagnosed in the past.
MN was the leading cause of nephrotic syndrome in middle age, whereas MCD was the most common histological [11] 2005
East China Jiangxi 1602 1205 320 952/650 29.6 (6-68) Du et al. [12] 2006
West China Shanxi 1542 1070 414 937/604 43.54 ± 15.3 Li et al. [13] 2006
North [14] 2009
South China Guangdong 1245 1031 170 506/739 9-73 Xu et al. [15] 2009
South [23] 2013
West China Xinjiang 1224 1000 149 661/563 4-82 Wei et al. [24] 2013
East China Shandong 1071 795 258 538/533 7-81 Liu and Zhang [25] 2014
West China Yunnan 1594 893 550 894/700 45.54 ± 10.44 Zhang et al. [4] 2014
North China Beijing 11,608 8209 2406 6646/4972 35 (3-85) Sun et al. [26] 2014
West China Shanxi 1363 1119 209 712/651 37.0 ± 7.8 Yang et al. [27] 2015
North China Jilin 4382 2781 1341 2434/1948 6-82 Li et al. [28] 2016
East China Anhui 1217 1022 186 666/551 34.5 ± 15.8 Xu et al. [29] 2016
South China diagnosis among younger patients. The detection rate of MN was about 20% in Brazil [38] and Italy [35] and 10% in the USA. [32] In Asia, MN was not as common in the past, but its incidence is increasing. [6, 29, 36] The presence of unidentified environmental factors, such as PM2.5, may increase the risk of MN. [29] In recent years, the incidence of FSGS has tended to increase in the USA [39] and Brazil, [40] but it dropped in our study. The area-varying distribution of FSGS might be related to race and environmental factors. [39] LN is the most common SGN worldwide, comprising 45.5-66.2% of all SGN. [31, 32, 34, 38] Our data showed a nonsignificant tendency for a decrease in the detection rate by decade. With advances in clinical medicine and technology, more autoimmune diseases are being identified and diagnosed, which may explain the trend in LN.
The prevalence of DN increased significantly after 2010. It is SGN caused by diabetes mellitus and is one of the most common diabetic complications. The prevalence of type 2 diabetes mellitus has increased rapidly in recent decades, and it has become a global public health problem. Diabetes is the leading cause of CKD in developed countries, whereas glomerulonephritis has been identified as the predominant cause of CKD in developing countries. Zhang et al [41] was the first to report that CKD was more frequently associated with diabetes than glomerulonephritis in China, in both the general population and a hospitalized urban population. DN will likely play a more important role in the spectrum of SGN in China in the coming decades. This present study also had limitations. Due to the high heterogeneity, the existing data are not suitable for meta-analysis. The inter-regional and regional differences and heterogeneity may be related to many factors. The reasons for the differences between regions are complex and may involve nationality, population mobility, economic conditions, education, environment, diet, and other factors. Second, there are significant differences in renal biopsy indications between regions; in some areas, it is considered only in patients with nephrotic syndrome and normal renal function. This will undoubtedly lead to heterogeneity in the spectrum of renal biopsy between hospitals. Third, the production and staining process of kidney sections and the diagnostic accuracy of pathologist differ across regions. In some underdeveloped areas, this is still a long way to go. Clinicians and pathologists in different provinces and cities require standardized training and the uniform guidelines are needed urgently.
In summary, although decreasing gradually, IgAN and MsPGN are still the most common types of PGN in patients undergoing renal biopsies in China, whereas LN is still the top SGN. The detection rates of MN, MCD, and DN are tending to increase, while that of FSGS is dropping. Differences between regions are related to various factors. Unified standards for assessing renal biopsies are urgently needed. 
Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website.
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